Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

QKI-7 targeting restores endothelial cell function and improves vascular complications in diabetes

Sep. 8, 2020

New severe aortic valve calcification and stenosis rabbit model developed

Sep. 7, 2020

BIAL presents phase I data on the dopamine beta-hydroxylase inhibitor zamicastat

Sep. 3, 2020

Agios Pharmaceuticals identifies PKM2 and PKLR activators

Sep. 3, 2020

Nicotinamide riboside suppresses inflammatory activation of PBMC in heart failure

Aug. 26, 2020

New model displays transition to cardiac failure and reverse modeling

Aug. 18, 2020

Specific miRNA-1 oxidation encodes cardiac hypertrophy

Aug. 17, 2020

First-in-human data for anti-miR-92a therapy, MRG-110

Aug. 12, 2020

Six-month follow-up data announced from phase I study of INXN-4001

Aug. 7, 2020

Phase III EMPEROR-Reduced trial of empagliflozin in HFrEF meets primary endpoint

July 31, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...